#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia recurrent Spinal muscular atrophy Arrhythmia Polycystic liver disease Osteosarcoma Diffuse large B-cell lymphoma Fibrodysplasia ossificans progressiva Paraneoplastic neurological syndrome Lymphangioma Waldenstrom's macroglobulinaemia recurrent Neuroendocrine tumour Neuromyelitis optica spectrum disorder Scedosporium infection B-cell small lymphocytic lymphoma refractory Thalassaemia More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma Bronchopulmonary dysplasia – Trials in Disease Wolfram syndrome – Basic Information Sarcoidosis – Basic Information Chronic granulomatous disease – Diagnostics Langerhans cell sarcoma – Basic Information Propionic acidaemia – Diagnostics Haemophilia A without inhibitors – Basic Information Splenic marginal zone lymphoma – Life with Disease Glycogen storage disease type I – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    UDONITRECTAG 68Ganota-Anti-Her2 Vhh1 Permethrin Bms-986340 Ezetimibe Hydroxypropylbetadex Rineterkib Nortriptyline Hydrochloride Morphine Hydrochloride Citicoline Sodium Efanesoctocog Alfa 64Cu-Dota-Ae105 Zipalertinib Minocycline Oxybutynin THEOPHYLLINE ANHYDROUS L-Threonine Potassium Canrenoate Thiamine Nitrate Bp Glucose More therapies…

    Learn about Your Condition

    Postoperative delirium Hepatobiliary disease Rectal neoplasm Angiosarcoma metastatic Immune-mediated myositis Thyroid cancer Corticobasal degeneration Corneal graft rejection Ligament operation Septic shock Femoral hernia Thrombotic microangiopathy Brain neoplasm malignant Oral neoplasm Usher's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ischaemic stroke

  • Study on Blood Pressure Management with Urapidil, Phenylephrine, and Labetalol for Patients with Acute Ischemic Stroke After Endovascular Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Labetalol Hydrochloride
    • Phenylephrine Hydrochloride
    • Urapidil
    Spain

  • Study on the Safety of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Patients with Acute Ischemic Stroke

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Allogeneic Adipose-Derived Mesenchymal Stem Cells Expanded
    Spain

  • Study on Tirofiban and Aspirin for Patients with Acute Ischemic Stroke Due to Tandem Lesion

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • D,L-Lysine Acetylsalicylate
    • Tirofiban Hydrochloride Monohydrate
    • Clopidogrel
    Spain

  • Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Glenzocimab
    • Gadobutrol
    France

  • Study on the Safety and Effectiveness of LT3001 for Patients with Acute Ischemic Stroke

    Not recruiting

    2 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Lt3001
    Czechia Germany Greece Italy Portugal Spain

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14
Previous Page
1 … 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!